Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrating Novel NeuroImaging Measurements and Circulating Biomarkers for the Prediction of Secondary Injury foLlowing strokE: From Bench to Bedside - The NIMBLE Study (NIMBLE)

NCT07422636 is registered in ClinicalTrials.gov with University of Florence as lead sponsor.

NCT NCT07422636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07422636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrating Novel NeuroImaging Measurements and Circulating Biomarkers for the Prediction of Secondary Injury foLlowing strokE: From Bench to Bedside - The NIMBLE Study (NIMBLE)
Lead sponsor
University of Florence
Phase
Observational
Overall status
Completed
Start date
April 17, 2021
Completion date
December 31, 2024
Enrollment
213 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke, animal model, cerebral edema, hemorrhagic transformation due to acute stroke, reperfusion injury